←
Benoit Lehallier115 posts
Benoit Lehallier avatar

Benoit Lehallier

@blehall

#Nonlinearthinker #Omicsaholic

◷ Joined January 2012▧ 36 Photos and videos
Andrew C. Yang avatar
⟳ Benoit Lehallier retweeted
Andrew C. Yang@andcyang·Nov 13

What if the blood-brain barrier were more than a barrier? Led by Haoyue @zho30045, we mapped the BBB transportome: diverse blood proteins imported and routed for brain health. This peripheral support withdraws early in Alzheimer’s models, and restoring APOA1 rescued dysfunction

Post attachment

Excited to share our work from the @andcyang lab, now out in @CellCellPress! 🧵 1/7 We asked what the blood-brain barrier lets in, not just what it blocks. It turns out to import neuroprotective blood proteins, and Alzheimer’s models lose this early. 🔗 cell.com/cell/fulltext/S0092…

Benoit Lehallier avatar
Benoit Lehallier@blehall·Mar 26

This work was funded by MJFF and built on Alkahest/Grifols' unique sample repository. Massive team effort - full author list and data access info coming with preprint. The data will be made fully available to the research community. Early access possible 🔓

Benoit Lehallier avatar
Benoit Lehallier@blehall·Mar 26

What this means: 1️⃣ Early detection may be possible using blood tests 2️⃣ Novel pathways (CXCL12 axis) point to new therapeutic targets 3️⃣ The Chronos platform can be extended at scale to other diseases

Post attachment
Benoit Lehallier avatar
Benoit Lehallier@blehall·Mar 26

Perhaps most importantly: we can now track how distinct proteins evolve over time in people who will develop PD. This opens the door to molecular trajectory profiling - moving from symptom-based diagnosis to early molecular detection.

Post attachment
Benoit Lehallier avatar
Benoit Lehallier@blehall·Mar 26

The real-world data linkage is key. By connecting proteomics to longitudinal clinical records, we can dissect when molecular changes emerge but also how they relate to comorbidities, medications and more. This granularity isn't possible with traditional case-control designs.

Post attachment
Benoit Lehallier avatar
Benoit Lehallier@blehall·Mar 26

A striking early signal: coordinated alterations in the CXCL12–cell adhesion molecules–integrin axis. This signaling network governs: - Leukocyte trafficking - Blood-brain barrier integrity - Neuroinflammation These changes appear years before clinical diagnosis.

Post attachment
Benoit Lehallier avatar
Benoit Lehallier@blehall·Mar 26

We reproduced known PD biomarkers from clinically-phenotyped cohorts, validating our unique population-scale approach. But we also found something new.

Post attachment
Benoit Lehallier avatar
Benoit Lehallier@blehall·Mar 26

We profiled 2,609 samples using FOUR complementary proteomics platforms - measuring over 25,000 proteoforms. Samples span from 12 years before diagnosis to 9 years after. This is the deepest longitudinal proteomic profiling of PD to date.

Post attachment
Benoit Lehallier avatar
Benoit Lehallier@blehall·Mar 26

Chronos uses privacy-preserving tokenization to link archived plasma samples with longitudinal clinical records. Starting from 100+ million routine-donation samples from 3 million donors, we assembled a carefully matched cohort of 348 PD cases and 348 controls.

Post attachment
Benoit Lehallier avatar
Benoit Lehallier@blehall·Mar 26

Most PD biomarker studies can only look at patients after diagnosis. But by the time tremors appear, neurodegeneration has already been underway for years. To find the earliest signals, we needed to go back in time - into the pre-symptomatic phase.

Post attachment
Benoit Lehallier avatar
Benoit Lehallier@blehall·Mar 26

What if we could detect Parkinson's disease up more than a decade before symptoms appear? We just published results from Chronos-PD, leveraging a unique resource: 100+ million archived plasma samples from routine donations. Here's what we found 🧵 medrxiv.org/content/10.64898…

Benoit Lehallier avatar
Benoit Lehallier@blehall·14 Jan 2025

Learn more about this pioneering initiative and MJFF's impactful grant funding here: 👉 Chronos-PD Grant Details michaeljfox.org/grant/chrono… (5/5)

Benoit Lehallier avatar
Benoit Lehallier@blehall·14 Jan 2025

💡 The team is making rapid progress, and groundbreaking results are just around the corner—stay tuned for updates! Honored to be the #PI of this transformative program (4/5)

Benoit Lehallier avatar
Benoit Lehallier@blehall·14 Jan 2025

Our work aims to identify plasma-based biomarkers that could predict Parkinson’s disease years before clinical diagnosis. With Chronos-PD, we are paving the way for earlier diagnostics and groundbreaking therapies across multiple diseases (3/5)